Pharming Group N.V.
PHAR
$16.24
$0.030.15%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | -11.84M | -17.82M | -13.33M | |
| Total Depreciation and Amortization | -- | 10.19M | 10.13M | 10.29M | |
| Total Amortization of Deferred Charges | -- | 852.00K | 884.00K | 884.00K | |
| Total Other Non-Cash Items | -- | 9.08M | 11.64M | 12.67M | |
| Change in Net Operating Assets | -- | -10.07M | -4.37M | -16.28M | |
| Cash from Operations | -- | -1.80M | 451.00K | -5.76M | |
| Capital Expenditure | -- | -790.00K | -964.00K | -745.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | 32.41M | 38.46M | -24.33M | |
| Cash from Investing | -- | 31.62M | 37.50M | -25.08M | |
| Total Debt Issued | -- | 104.54M | 104.54M | 104.80M | |
| Total Debt Repaid | -- | -138.64M | -137.32M | -137.34M | |
| Issuance of Common Stock | -- | 5.58M | 3.74M | 12.26M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -5.89M | -4.19M | -6.28M | |
| Cash from Financing | -- | -34.41M | -33.23M | -26.56M | |
| Foreign Exchange rate Adjustments | -- | -2.21M | 1.29M | -488.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -6.80M | 6.01M | -57.88M | |